Comparison of Multigam® IV (5% vs. 10%) in hematological patients with a secondary immunodeficiency to evaluate infusion time, tolerability and satisfaction. A monocentric observational Belgian study.

0 views
0 downloads

Powered byMorressier logo black

Discover more research and events on morressier.com